[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2005/209246,2005,A1Locationinpatent:Page/Pagecolumn46-48;54
[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2007/155702,2007,A1Locationinpatent:Page/Pagecolumn12
[1]Fox,RichardJ.;Tripp,JonathanC.;Schultz,MitchellJ.;Payack,JosephF.;Fanfair,DayneD.;Mudryk,BoguslawM.;Murugesan,Saravanababu;Chen,Chung-PinH.;LaCruz,ThomasE.;Ivy,SabrinaE.;Broxer,Sévrine;Cullen,Ryan;Erdemir,Deniz;Geng,Peng;Xu,Zhongmin;Fritz,Alan;Doubleday,WendelW.;Conlon,DavidA.[OrganicProcessResearchandDevelopment,2017,vol.21,#8,p.1095-1109]
[2]Fox,RichardJ.;Tripp,JonathanC.;Schultz,MitchellJ.;Payack,JosephF.;Fanfair,DayneD.;Mudryk,BoguslawM.;Murugesan,Saravanababu;Chen,Chung-PinH.;LaCruz,ThomasE.;Ivy,SabrinaE.;Broxer,Sévrine;Cullen,Ryan;Erdemir,Deniz;Geng,Peng;Xu,Zhongmin;Fritz,Alan;Doubleday,WendelW.;Conlon,DavidA.[OrganicProcessResearchandDevelopment,2017,vol.21,#8,p.1095-1109]
[3]Wang,Tao;Ueda,Yasu;Zhang,Zhongxing;Yin,Zhiwei;Matiskella,John;Pearce,BradleyC.;Yang,Zheng;Zheng,Ming;Parker,DawnD.;Yamanaka,GregoryA.;Gong,Yi-Fei;Ho,Hsu-Tso;Colonno,RichardJ.;Langley,DavidR.;Lin,Pin-Fang;Meanwell,NicholasA.;Kadow,JohnF.[JournalofMedicinalChemistry,2018,vol.61,#14,p.6308-6327]
Title: Nowicka-Sans B, et al. In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068. Antimicrob Agents Chemother. 2012 Jul;56(7):3498-507.
